Your Weekly Dose of News in Pharma, Biotech and Health
In global health, efforts are underway to rekindle vaccine leadership in the EU, while the fight against AIDS, TB, and malaria faces challenges due to climate change. In marketing, Novartis employs sculptures to raise awareness of cancer symptoms, and Gilead Sciences publishes a unique, difficult-to-read book to highlight marginalized patients. In the MedTech sector, Mayo Clinic and GE Healthcare collaborate on tech-driven theranostic imaging. A survey reveals that most pharmaceutical companies are not adequately prepared for future challenges like AI advances and IRA legislation. In politics, President Biden's Cancer Moonshot initiatives are scrutinized, and Ursula von der Leyen's health remarks in a European Union speech draw attention. The Biden administration takes on the US drugs industry, and in regulatory news, the FDA proposes changes to a key approval pathway for medical devices, five years after making promises to do so.
Photo credit: Gilead Sciences
Global Health
Reigniting vaccine leadership in the EU
Climate change impeding fight against AIDS, TB and malaria
Marketing
Novartis makes sculptures to shape knowledge of cancer symptoms
Gilead Sciences opens a new chapter, publishes the world's 'hardest book to read' to reveal patients stuck in the margins
MedTech
Mayo Clinic, GE HealthCare launch tech-driven theranostic imaging collaboration
Pharma
Most pharma companies are not ‘future ready’ as pressure mounts from AI advances and IRA legislation, survey finds
Politics
What to make of Biden’s latest Cancer Moonshot efforts
Von der Leyen accidentally went up against Biden on health — and lost
The Biden administration takes on the US drugs industry
Regulatory
FDA proposes changes to key approval pathway for medical devices, five years after promising
For an overview of previous Weekly Notables, visit our Archive